Kidney Transplantation clinical trials
70 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
- TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation
- Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
- Advancing Transplantation Outcomes in Children
- Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
- A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
- The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
- Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
- Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
- Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
- Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
- Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
- Shingrix in Renal Transplant Recipients
- Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
- Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
- Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
- Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
- An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
- Empagliflozin Treatment in Kidney Transplant Recipients
- Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
- Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
- Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
- REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
- CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
- Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
- Double Voiding and Post-transplant UTI
- Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
- Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
- A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
- Immune Registry for BK in Kidney Transplant Recipients
- The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
- Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
- Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
- Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
- The Mycophenolate Pregnancy Registry
- The KidneyCARE (Community Access to Research Equity) Study
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
- Use of CGM in Kidney Transplant Recipients
- Sympatholysis in Chronic Kidney Disease
- Pilot Trial of Supplemental Vitamin A and Nicotinamide
- Prehabilitation for Kidney Transplant Candidates
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Kidney Transplantation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.